在高度敏感的患者中,适度风险退出名单的策略
Carolina Castro Hernández1, Daniel de la Sierra1, Mónica Renuncio-García1
1Immunology Department, Immunopathology Group, Marqués de Valdecilla University Hospital-IDIVAL, Santander, Spain.
Transplantation proceedings
|January 7, 2025
概括
降低计算面板反应性抗体 (cPRA) 的策略对于等待移植的高度敏感 (HS) 患者至关重要. 规模删除 (DL) 方法提供了一个有前途的治疗策略,以改善这些患者的移植机会.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 免疫学 免疫学 免疫学
- 移植 移植 移植 移植
背景情况:
- 捐赠者交换计划没有改善高度敏感 (HS) 患者的等待列表结果,其中100%的计算面板反应性抗体 (cPRA).
- 新的脱敏治疗方法,如imlifidase存在,但需要减少cPRA的策略.
- 将cPRA降低到<99.95%显著增加了捐赠者提供机会,突出了删除 (DL) 策略的重要性.
研究的目的:
- 为在移植等待名单上拥有100%cPRA的HS患者提出一个完整的,规模化的删除 (DL) 方法.
- 为了评估HS患者从低到中等风险的退出名单.
主要方法:
- 删除标准包括历史平均光强度 (MFI) <5000 (低风险阶段).
- 中级风险删除涉及单抗原测试 (MFI <3000),有或没有先前移植的片不匹配.
- 分子不匹配评估可以使用注册表不匹配计算器工具进行.
主要成果:
- 低风险的删除方法是减少HS患者cPRA的常见方法.
- 这些方法并不总是足以成功移植,需要新的工具.
- 一些用imlifidase治疗的患者经历了抗人类白细胞抗原反弹,增加了排斥风险.
结论:
- 为高度敏感 (HS) 患者提出了规模删除 (DL) 方法作为优越的治疗策略.
- 这种方法旨在通过减少cPRA来改善HS患者的移植机会.
- 进一步开发删除策略对于优化等待移植的HS患者的治疗结果至关重要.
相关概念视频
01:20Desensitization and Tachyphylaxis
1.5K
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
1.5K
01:28Drug Therapy
37
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
37
01:19Pharmacovigilance
771
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
771
01:30Hypersensitivities
501
Hypersensitivity, also known as a hypersensitivity reaction or allergic reaction, is a condition where the body's immune system reacts abnormally to a foreign substance. Such substances, that cause hypersensitivity are referred to as an allergen, could be something typically harmless to most people, like pollen or certain foods.
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
Types of Hypersensitivities
Hypersensitivity reactions are categorized into four types: Type 1, Type 2, Type 3, and Type 4. Each type has a distinct mechanism...
501